Ventaira Pharmaceuticals Inc is categorized under Commercial Physical Research in Columbus, OH and active since 1999.
Ventaira Pharmaceuticals Inc was established in 1999, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Commercial Physical Research business, which does work in the B2B market, and is classified as a Commercial Physical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Leslie J Williams at the company’s single location by writing to 505 King Avenue 118, Columbus, Ohio OH 43201 or by phoning (614) 340-2325. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ventaira Pharmaceuticals Inc |
| Contact Person: | Leslie J Williams |
| Address: | 505 King Avenue 118, Columbus, Ohio 43201 |
| Phone Number: | (614) 340-2325 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Physical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Ventaira Pharmaceuticals Inc was started in 1999 to provide professional Commercial Physical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Leslie J Williams for inquiries that concern Ventaira Pharmaceuticals Inc by calling the company number (614) 340-2325, as your correspondence is most welcome. Additionally, the physical location of the single location of Ventaira Pharmaceuticals Inc can be found at the coordinates 39.990513,-83.020111 as well as the street address 505 King Avenue 118 in Columbus, Ohio 43201.
For its online presence, you may visit Ventaira Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.